GSK eyes sharper, faster drug development as new CEO signals growth plan

By Bhanvi Satija and Pushkala Aripaka LONDON, Feb 4 (Reuters) - GSK's new CEO Luke Miels said on Wednesday that the drugmaker ...
The New York Times

Zantac’s Developer Settles Lawsuits Claiming Cancer Link

GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion. By Rebecca Robbins The British drug maker GSK said on Wednesday that it ...
Morningstar

GSK Licenses Noetik’s AI Foundation Models in Anchor Partnership to Transform Cancer Therapeutic Research and Development

Noetik, an AI-native biotech company pioneering self-supervised machine learning and high-throughput spatial data to develop next-generation cancer therapeutics, announced today a five-year strategic ...